comparemela.com

Latest Breaking News On - துறை ஆஃப் மூலக்கூறு பரிசோதனை - Page 1 : comparemela.com

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

 E-Mail IMAGE: Ajay Goel, Ph.D., M.S., chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope, and his colleagues developed a novel, noninvasive liquid biopsy test for detecting. view more  Credit: City of Hope DUARTE, Calif. Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma. Research on the development of the blood test was reported in a new study published in Gastroenterology, a journal of the American Gastroenterological Association.

New blood-based test detects lymph node metastasis in individuals with high-risk T1 colorectal cancer

New blood-based test detects lymph node metastasis in individuals with high-risk T1 colorectal cancer Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma. Research on the development of the blood test was reported in a new study published in Gastroenterology, a journal of the American Gastroenterological Association. This blood-based test is an example of the theranostic (a term that combines therapeutic and diagnostic ) approach at City of Hope, whose goal is to help every patient receive personalized treatment appropriate for their specific disease. Development of blood-based biopsies to detect and monitor tumors is one of the leading-edge technologies under investigation to help patients with cancer.

Analyzing short strands of cell-free DNA in urine could help detect early-stage cancer

Analyzing short strands of cell-free DNA in urine could help detect early-stage cancer Urinalysis has long been a staple of physical exams to detect and manage a number of diseases and disorders, but not cancer. What if it were that easy, though, and cancer was detected in its very earliest stages when the disease responds more favorably to treatment and improved outcomes are more likely? That was the question posed by scientists at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, who have found a way of zeroing in on early-stage cancer by analyzing short strands of cell-free DNA in urine. Their study s findings were published today in the scientific journal

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.